Richard Condon, CEO Aspire Pharma, discusses successful leadership
Leading lights
Related Posts
Amgen’s Tepezza granted marketing authorisation in the UK
Teprotumumab approved as first targeted treatment for thyroid eye disease The UK’s Medicines and Healthcare […]
WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants The World Health Organization (WHO) […]
MHRA approves prostate cancer imaging agent trofolastat
Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK The […]